The vesicular amine transporter family (SLC18): amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Pflügers Archiv

• Publication date

  2004-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00424-003-1100-5PMID 12827358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reserpine- and tetrabenazine-sensitive transport of3H-histamine by the neuronal isoform of the vesicular monoamine transporter

  2007cited by this paper
• Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat

  2007cited by this paper
• Expression of the Two Isoforms of the Vesicular Monoamine Transporter (VMAT1 and VMAT2) in the Endocrine Pancreas and Pancreatic Endocrine Tumors

  2003cited by this paper
• An Amino Acid Cluster around the Essential Glu-14 Is Part of the Substrate- and Proton-binding Domain of EmrE, a Multidrug Transporter from Escherichia coli *

  2003cited by this paper
• Characterization of an Archaeal Multidrug Transporter with a Unique Amino Acid Composition*

  2003cited by this paper
• Identification of human vesicle monoamine transporter (VMAT2) lumenal cysteines that form an intramolecular disulfide bond.

  2002cited by this paper
• Catecholamine research : from molecular insights to clinical medicine

  2002cited by this paper
• Neurogenetics of vesicular transporters in C. elegans

  2000cited by this paper
• Transport mechanisms in acetylcholine and monoamine storage

  2000cited by this paper
• The vesicular neurotransmitter transporters: current perspectives and future prospects

  2000cited by this paper
• Tyrosine hydroxylase‐expressing and/or aromatic L‐amino acid decarboxylase‐expressing neurons in the mediobasal hypothalamus of perinatal rats: Differentiation and sexual dimorphism

  2000cited by this paper
• The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulnerability to dopaminergic toxins

  2000cited by this paper
• Molecular analysis of vesicular amine transporter function and targeting to secretory organelles

  2000cited by this paper
• In vivo imaging of the vesicular acetylcholine transporter and the vesicular monoamine transporter

  2000cited by this paper
• Chemical neuroanatomy of the vesicular amine transporters

  2000cited by this paper
• Membrane trafficking of neurotransmitter transporters in the regulation of synaptic transmission.

  1999cited by this paper
• Mutational Analysis of Aspartate Residues in the Transmembrane Regions and Cytoplasmic Loops of Rat Vesicular Acetylcholine Transporter*

  1999cited by this paper
• The cat-1 Gene of Caenorhabditis elegansEncodes a Vesicular Monoamine Transporter Required for Specific Monoamine-Dependent Behaviors

  1999cited by this paper
• The Cholinergic Gene Locus

  1998cited by this paper
• Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.

  1998cited by this paper
• Transient developmental expression of monoamine transporters in the rodent forebrain.

  1998cited by this paper
• VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity.

  1997cited by this paper
• Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.

  1997cited by this paper
• Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.

  1997cited by this paper
• Charged Residues in Transmembrane Domains II and XI of a Vesicular Monoamine Transporter Form a Charge Pair That Promotes High Affinity Substrate Recognition*

  1997cited by this paper
• Topology prediction for helical transmembrane proteins at 86% accuracy–Topology prediction at 86% accuracy

  1996cited by this paper
• Modification of the pH Profile and Tetrabenazine Sensitivity of Rat VMAT1 by Replacement of Aspartate 404 with Glutamate*

  1996cited by this paper
• PHD: predicting one-dimensional protein structure by profile-based neural networks.

  1996cited by this paper
• Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.

  1996cited by this paper
• Differential expression of two vesicular monoamine transporters

  1995cited by this paper
• Identification of Residues Involved in Substrate Recognition by a Vesicular Monoamine Transporter (*)

  1995cited by this paper
• Vesicular neurotransmitter transporters: from bacteria to humans.

  1995cited by this paper
• Transport of histamine by vesicular monoamine transporter-2.

  1995cited by this paper
• From Bacterial Antibiotic Resistance to Neurotransmitter Uptake

  1994cited by this paper
• Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus.

  1994cited by this paper
• From bacterial antibiotic resistance to neurotransmitter uptake. A common theme of cell survival.

  1994cited by this paper
• Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules

  1994cited by this paper
• The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter.

  1993cited by this paper
• Acetylcholine transport, storage, and release.

  1993influential reference
• Topology, structure and evolution of two families of proteins involved in antibiotic and antiseptic resistance in eukaryotes and prokaryotes--an analysis.

  1993cited by this paper
• Functional Identification and Molecular Cloning of a Human Brain Vesicle Monoamine Transporter

  1993cited by this paper
• Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium.

  1992cited by this paper
• A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter.

  1992cited by this paper
• Expression cloning of a reserpine-sensitive vesicular monoamine transporter.

  1992cited by this paper
• Membrane transport proteins: implications of sequence comparisons.

  1992cited by this paper
• Immunoaffinity Purification of Human Choline Acetyltransferase: Comparison of the Brain and Placental Enzymes

  1985cited by this paper

• Molecular basis of vesicular monoamine transport and neurological drug interactions

  2025cites this paper
• Novel Ways of Targeting the Dopamine Transporter.

  2025cites this paper
• Prenatal exposure to methadone or buprenorphine alters transcriptional networks associated with synaptic signaling in newborn rats.

  2025cites this paper
• Transcriptomic analysis of effects of developmental PCB exposure in the hypothalamus of female rats

  2025cites this paper
• Placental transcriptome reveals the placental brain axis genes and pathways of gestational diabetes mellitus (GDM) affecting offspring neurodevelopment.

  2025cites this paper
• Evolution of canonical circadian clock genes underlies unique sleep strategies of marine mammals for secondary aquatic adaptation

  2025cites this paper
• The role of the vesicular monoamine transporter 2 in the inhibitory effect of tetrabenazine and valbenazine compared to reserpine on the vesicular release of monoamine transmitters

  2025cites this paper
• Serotonergic Mechanisms in Proteinoid-Based Protocells

  2025cites this paper
• Drug inhibition and substrate transport mechanisms of human VMAT2

  2025cites this paper
• Structural insights into substrate transport and drug inhibition of the human vesicular monoamine transporter 2 (VMAT2)

  2025cites this paper
• Structural insights into vesicular monoamine storage and drug interactions

  2024influential citation
• Neurotransmitter recognition by human vesicular monoamine transporter 2

  2024cites this paper
• Engineering of a mammalian VMAT2 for cryo-EM analysis results in non-canonical protein folding

  2024cites this paper
• Structural mechanisms for VMAT2 inhibition by tetrabenazine

  2024cites this paper
• Effects of extracellular metabolic acidosis and out-of-equilibrium CO2/HCO3 − solutions on intracellular pH in cultured rat hippocampal neurons

  2024cites this paper
• Transport and inhibition mechanism for VMAT2-mediated synaptic vesicle loading of monoamines

  2024cites this paper
• A novel class of insecticidal alkylsulfones are potent inhibitors of vesicular acetylcholine transport.

  2024cites this paper
• Characterization of Freshly Isolated Human Peripheral Blood B Cells, Monocytes, CD4+ and CD8+ T Cells, and Skin Mast Cells by Quantitative Transcriptomics

  2024cites this paper
• Biochemically silent normotensive colossal pheochromocytoma

  2024cites this paper
• Discovery of 1,2,4-Oxadiazole Derivatives Containing Haloalkyl as Potential Acetylcholine Receptor Nematicides

  2023cites this paper
• Chronic stress induces pulmonary epithelial cells to produce acetylcholine that remodels lung pre-metastatic niche of breast cancer by enhancing NETosis

  2023cites this paper
• Neurochemical mechanisms of deep brain stimulation for depression in animal models.

  2023cites this paper
• Rare disease research workflow using multilayer networks elucidates the molecular determinants of severity in Congenital Myasthenic Syndromes

  2023cites this paper
• Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions

  2023cites this paper
• Transport and inhibition mechanisms of human VMAT2

  2023cites this paper
• Disruption of Dopamine Homeostasis Associated with Alteration of Proteins in Synaptic Vesicles: A Putative Central Mechanism of Parkinson’s Disease Pathogenesis

  2023cites this paper
• Effect of aminergic signaling on the humoral innate immunity response of Drosophila

  2023cites this paper
• The monoaminergic system is a bilaterian innovation

  2023cites this paper
• Transport and inhibition mechanism for VMAT2-mediated synaptic loading of monoamines

  2023cites this paper
• Structural mechanisms for VMAT2 inhibition by tetrabenazine

  2023cites this paper
• Solute carrier (SLC) expression reveals skeletogenic cell diversity

  2023cites this paper
• Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders

  2022cites this paper
• Flexible and Transparent Composite Electrode with 3D Freestanding Architecture for Dopamine Monitoring

  2022cites this paper
• Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.

  2022cites this paper
• Role of Protein Damage Inflicted by Dopamine Metabolites in Parkinson's Disease: Evidence, Tools, and Outlook.

  2022cites this paper
• Autoantibody Profiling of Monoamine Oxidase A Knockout Mice, an Autism Spectrum Disorder Model.

  2022cites this paper
• Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers

  2022cites this paper
• Differential Expression of Secretogranins II and III in Canine Adrenal Chromaffin Cells and Pheochromocytomas

  2022cites this paper
• Serum unsaturated phosphatidylcholines predict longitudinal basal forebrain degeneration in Alzheimer’s disease

  2022cites this paper
• Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration

  2022cites this paper
• Neuromodulation by Monoamines is a Bilaterian Innovation

  2022cites this paper
• Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons

  2022cites this paper
• Cranial manipulation affects cholinergic pathway gene expression in aged rats

  2022cites this paper
• Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity

  2021influential citation
• Neurotransmitter Transporters and Their Role in the Pharmacological Actions of Therapeutic and Abused Drugs

  2021cites this paper
• Role of Oxidative Stress in the Etiology of Parkinson’s Disease: Advanced Therapeutic Products

  2021cites this paper
• PET Imaging of VMAT2 with the Novel Radioligand [18F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [11C]DTBZ and [18F]FE-DTBZ

  2021cites this paper
• Colorectal cancer in Crohn's disease evaluated with genes belonging to fibroblasts of the intestinal mucosa selected by NMF.

  2021cites this paper
• Dysfunction of Synaptic Vesicle Endocytosis in Parkinson’s Disease

  2021cites this paper
• Stable expression of the human dopamine transporter in N27 cells as an in vitro model for dopamine cell trafficking and metabolism.

  2021cites this paper
• The Kidney Beans (Phaseolus vulgaris) Pods Extract Affects the Central and Peripheral Serotonergic Systems in Rats With High-Calorie Diet-Induced Obesity

  2021cites this paper
• Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis

  2020cites this paper
• Cranial Manipulation Modulates Cholinergic Pathway Gene Expression in an Animal Model of Age-related Cognitive Decline

  2020cites this paper
• Cranial Manipulation Affects Cholinergic Pathway Gene Expression in an Animal Model of Age-related Cognitive Decline

  2020cites this paper
• Recent advances with 5-HT3 modulators for neuropsychiatric and gastrointestinal disorders.

  2020cites this paper
• Vesicular polyamine transporter as a novel player in amine-mediated chemical transmission.

  2020cites this paper
• Interesterified fat consumption since gestation decreases striatal dopaminergic targets levels and gdnf impairing locomotion of adult offspring.

  2020cites this paper
• Genetic regulators of ventral midbrain gene expression and nigrostriatal circuit integrity

  2020cites this paper
• Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis

  2020cites this paper
• PET Imaging of Vesicular Monoamine Transporters

  2020cites this paper
• Alterations of the Motor and Olfactory Functions Related to Parkinson’s Disease in Transgenic Mice With a VMAT2-Deficiency in Dopaminergic Neurons

  2020cites this paper
• Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ethnic meta-analysis

  2020cites this paper
• Controversy of TMEM230 associated with Parkinson's Disease.

  2020cites this paper
• Radioligand Development for PET Imaging of the Vesicular Acetylcholine Transporter (VAChT) in the Brain

  2020cites this paper
• Discovery of 318 novel loci for type-2 diabetes and related micro- and macrovascular outcomes among 1.4 million participants in a multi-ethnic meta-analysis

  2019cites this paper
• PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics

  2019cites this paper
• High expression of VAT1 is a prognostic biomarker and predicts malignancy in glioblastoma.

  2019cites this paper
• The solute carrier transporters and the brain: Physiological and pharmacological implications

  2019cites this paper
• The Cholinergic System

  2019cites this paper
• Insight of Captagon Abuse by Chemogenomics Knowledgebase-guided Systems Pharmacology Target Mapping Analyses

  2019cites this paper
• Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.

  2019cites this paper
• Presynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters

  2019cites this paper
• Acetylcholine signaling system in progression of lung cancers

  2019cites this paper
• Physiopathological Role of the Vesicular Nucleotide Transporter (VNUT) in the Central Nervous System: Relevance of the Vesicular Nucleotide Release as a Potential Therapeutic Target

  2019cites this paper
• VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependence.

  2019cites this paper
• The Dopaminergic System

  2019cites this paper
• A Review: Use of Rauwolfia Serpentina for Antihypertensive Activity

  2019cites this paper
• Neurochemical organization of the ventral striatum’s olfactory tubercle

  2019cites this paper
• Mast Cells and Serotonin Synthesis Modulate Chagas Disease in the Colon: Clinical and Experimental Evidence

  2018cites this paper
• Computational study of SERT using new X-ray crystal structures and initial experimental verification of potential GABAB receptor compounds

  2018cites this paper
• Fast neurogenesis from carotid body quiescent neuroblasts accelerates adaptation to hypoxia

  2018cites this paper
• Allosteric interactions between catecholamine receptors and other G protein-coupled receptors: Pharmacological and functional characterization

  2018cites this paper
• Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness

  2018cites this paper
• The Long-term Effects of Chronic Antipsychotic Drug Treatment in Juvenile Rats on Adult Behavioural Attributes, Dopamine and Serotonin Neurotransmitter Systems

  2018cites this paper
• Dopamine: Functions, Signaling, and Association with Neurological Diseases

  2018cites this paper
• FUNCTIONAL AND BIOCHEMICAL CONSEQUENCES OF SINGLE NUCLEOTIDE POLYMORPHISMS IN THE HUMAN VESICULAR MONOAMINE TRANSPORTER 1 GENE ( SLC 18 A 1 )

  2018influential citation
• Network-based drug repositioning: A novel strategy for discovering potential antidepressants and their mode of action.

  2018cites this paper
• Gene Therapy for Parkinson’s Disease, An Update

  2018cites this paper
• AAH2 gene is not required for dopamine‐dependent neurochemical and behavioral abnormalities produced by Toxoplasma infection in mouse

  2018cites this paper
• Neural Secretions and Regulation of Gut Functions

  2018cites this paper
• The ins and outs of vesicular monoamine transporters

  2018cites this paper
• Chemical Digestion, Absorption, and Transport

  2018cites this paper
• Characterization of the CELF6 RNA Binding Protein: Effects on Mouse Vocal Behavior and Biochemical Function

  2018cites this paper
• Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain.

  2017influential citation
• Association study of the vesicular monoamine transporter 1 (VMAT1) gene with autism in an Iranian population.

  2017cites this paper
• Genetic polymorphism of vesicular monoamine transporter 1 gene (SLC18A1) in Emirati population

  2017cites this paper
• Mapping VTA neural circuits: periaqueductal inputs and mesohippocampal outputs

  2017cites this paper
• Proton electrochemical gradient: Driving and regulating neurotransmitter uptake.

  2017cites this paper
• Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-Guérin vaccination.

  2017cites this paper
• Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress

  2017cites this paper